Pharmacological actions of statins: potential utility in COPD
Chronic obstructive pulmonary disease (COPD) is characterised by minimally reversible airflow limitation and features of systemic inflammation. Current therapies for COPD have been shown to reduce symptoms and infective exacerbations and to improve quality of life. However, these drugs have little e...
Main Authors: | T. E. Eaton, R. Hopkins, R. P. Young |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2009-12-01
|
Series: | European Respiratory Review |
Subjects: | |
Online Access: | http://err.ersjournals.com/cgi/content/full/18/114/222 |
Similar Items
-
Statin Use and the Risk of Subsequent Hospitalized Exacerbations in COPD Patients with Frequent Exacerbations
by: Lin CM, et al.
Published: (2020-02-01) -
Statins and Pulmonary Hypertension in Chronic Obstructive Lung Disease
by: Sepide Hejazi, et al.
Published: (2020-03-01) -
Recommendations for the pharmacological treatment of COPD: questions and answers
by: Frederico Leon Arrabal Fernandes, et al. -
Statins in High-Risk Chronic Obstructive Pulmonary Disease Outpatients: No Impact on Time to First Exacerbation and All-Cause Mortality – The STATUETTE Cohort Study
by: Damkjær M, et al.
Published: (2021-03-01) -
Statins in High-Risk Chronic Obstructive Pulmonary Disease Outpatients: No Impact on Time to First Exacerbation and All-Cause Mortality – The STATUETTE Cohort Study [Corrigendum]
by: Damkjær M, et al.
Published: (2021-08-01)